# Computational design of high performance hybrid perovskite on silicon tandem solar cells

Preprint · A. Rolland, L. Pedesseau, A. Beck, M. Kepenekian, C. Katan, Y. Huang, S. Wang, C. Cornet, O. Durand, J. Even

- Archive id: arxiv:1509.01612
- Published: 2015-09-04
- arXiv: https://arxiv.org/abs/1509.01612
- Citations: 2
- Source URL: https://arxiv.org/abs/1509.01612
- PDF: https://arxiv.org/pdf/1509.01612
- Provenance: arxiv

## Abstract

In this study, the optoelectronic properties of a monolithically integrated series-connected tandem solar cell are simulated. Following the large success of hybrid organic-inorganic perovskites, which have recently demonstrated large efficiencies with low production costs, we examine the possibility of using the same perovskites as absorbers in a tandem solar cell. The cell consists in a methylammonium mixed bromide-iodide lead perovskite, CH3NH3PbI3(1-x)Br3x (0 \< x \< 1), top sub-cell and a single-crystalline silicon bottom sub-cell. A Si-based tunnel junction connects the two sub-cells. Numerical simulations are based on a one-dimensional numerical drift-diffusion model. It is shown that a top cell absorbing material with 20% of bromide and a thickness in the 300-400 nm range affords current matching with the silicon bottom cell. Good interconnection between single cells is ensured by standard n and p doping of the silicon at 5.10^19cm-3 in the tunnel junction. A maximum efficiency of 27% is predicted for the tandem cell, exceeding the efficiencies of stand-alone silicon (17.3%) and perovskite cells (17.9%) taken for our simulations, and more importantly, that of the record crystalline Si cells.

_Abstract reproduced under CC0-1.0 (arXiv descriptive metadata)._

Topics: [Perovskite & Tandem Photovoltaics](https://space-kitty.com/topics/advanced-photovoltaics)

---
Space Kitty Archive · https://space-kitty.com · API: https://space-kitty.com/api/v1 · MCP: https://space-kitty.com/mcp · Premium: $0.20/request via x402 (Base Sepolia (testnet)). Metadata: arXiv (CC0), OpenAlex (CC0), Europe PMC (CC BY/CC0 works), ClinicalTrials.gov.